Connection

David Cole to Female

Back to Details
This is a "connection" page, showing publications David Cole has written about Female.
David Cole
Connection Strength
0.423
Female
  1. Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer. J Hematol Oncol. 2017 04 07; 10(1):82.
    View in: PubMed
    Score: 0.030
  2. Soluble IL-15/IL-15Ra complexes in human serum. Blood. 2012 Jul 05; 120(1):1-2.
    View in: PubMed
    Score: 0.022
  3. Ex vivo interleukin-12-priming during CD8(+) T cell activation dramatically improves adoptive T cell transfer antitumor efficacy in a lymphodepleted host. J Am Coll Surg. 2012 Apr; 214(4):700-7; discussion 707-8.
    View in: PubMed
    Score: 0.021
  4. Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo. Cell Immunol. 2010; 261(2):134-43.
    View in: PubMed
    Score: 0.018
  5. Detection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: interim results of a prospective cohort study. BMC Cancer. 2008 Feb 20; 8:55.
    View in: PubMed
    Score: 0.016
  6. Predictors of cosmetic outcome following MammoSite breast brachytherapy: a single-institution experience of 100 patients with two years of follow-up. Int J Radiat Oncol Biol Phys. 2007 Jun 01; 68(2):354-8.
    View in: PubMed
    Score: 0.015
  7. Bystander effect contributes to the antitumor efficacy of CaSm antisense gene therapy in a preclinical model of advanced pancreatic cancer. Mol Ther. 2006 Feb; 13(2):357-65.
    View in: PubMed
    Score: 0.014
  8. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Ann Surg. 2004 Jun; 239(6):828-37; discussion 837-40.
    View in: PubMed
    Score: 0.012
  9. The molecular detection of micrometastatic breast cancer. Am J Surg. 2003 Oct; 186(4):351-8.
    View in: PubMed
    Score: 0.012
  10. Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int J Cancer. 2001 Jul 15; 93(2):162-71.
    View in: PubMed
    Score: 0.010
  11. Prognostic factors for residual occult disease in shave margins during partial mastectomy. Breast Cancer Res Treat. 2021 Sep; 189(2):471-481.
    View in: PubMed
    Score: 0.010
  12. A Multifaceted Approach to Opioid Education, Prescribing, and Disposal for Patients with Breast Cancer Undergoing Surgery. J Surg Res. 2021 01; 257:597-604.
    View in: PubMed
    Score: 0.010
  13. A pilot study evaluating the efficacy of a fully acetylated poly-N-acetyl glucosamine membrane formulation as a topical hemostatic agent. Surgery. 1999 Sep; 126(3):510-7.
    View in: PubMed
    Score: 0.009
  14. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination. Clin Cancer Res. 1999 May; 5(5):1173-82.
    View in: PubMed
    Score: 0.009
  15. Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panel. J Am Coll Surg. 1998 Jul; 187(1):9-16.
    View in: PubMed
    Score: 0.008
  16. Efficacy of reverse transcriptase-polymerase chain reaction screening for micrometastic disease in axillary lymph nodes of breast cancer patients. Am Surg. 1998 Jun; 64(6):539-43; discussion 543-4.
    View in: PubMed
    Score: 0.008
  17. Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8+ T Cells. Cancer Res. 2018 06 01; 78(11):3067-3074.
    View in: PubMed
    Score: 0.008
  18. Intrathoracic aberrant thyroid: identification critical for appropriate operative approach. Am Surg. 1998 Apr; 64(4):360-2.
    View in: PubMed
    Score: 0.008
  19. Stereotactic core biopsy of the breast: results of one-year follow-up of 101 patients. Am Surg. 1997 Dec; 63(12):1124-7.
    View in: PubMed
    Score: 0.008
  20. Surgical management of patients with intermediate thickness melanoma: current role of elective lymph node dissection. Semin Oncol. 1996 Dec; 23(6):719-24.
    View in: PubMed
    Score: 0.007
  21. Molecular Programming of Tumor-Infiltrating CD8+ T Cells and IL15 Resistance. Cancer Immunol Res. 2016 09 02; 4(9):799-811.
    View in: PubMed
    Score: 0.007
  22. Phase I study of recombinant CEA vaccinia virus vaccine with post vaccination CEA peptide challenge. Hum Gene Ther. 1996 Jul 10; 7(11):1381-94.
    View in: PubMed
    Score: 0.007
  23. Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors. J Control Release. 2015 Oct 28; 216:103-10.
    View in: PubMed
    Score: 0.007
  24. The impact of surgical diversion before neoadjuvant therapy for rectal cancer. Am Surg. 2015 May; 81(5):444-9.
    View in: PubMed
    Score: 0.007
  25. Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling. Clin Cancer Res. 2015 Jun 01; 21(11):2546-57.
    View in: PubMed
    Score: 0.007
  26. Postoperative complications in patients receiving suramin therapy. Surgery. 1994 Jul; 116(1):90-5.
    View in: PubMed
    Score: 0.006
  27. Histopathological analysis of metastatic melanoma deposits in patients receiving adoptive immunotherapy with tumor-infiltrating lymphocytes. Cancer Immunol Immunother. 1994 May; 38(5):299-303.
    View in: PubMed
    Score: 0.006
  28. Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2014 Mar 15; 88(4):837-44.
    View in: PubMed
    Score: 0.006
  29. Tumor priming enhances siRNA delivery and transfection in intraperitoneal tumors. J Control Release. 2014 Mar 28; 178:79-85.
    View in: PubMed
    Score: 0.006
  30. Phase I trial of recombinant human macrophage colony-stimulating factor administered by continuous intravenous infusion in patients with metastatic cancer. J Natl Cancer Inst. 1994 Jan 05; 86(1):39-45.
    View in: PubMed
    Score: 0.006
  31. Activity of drug-loaded tumor-penetrating microparticles in peritoneal pancreatic tumors. Curr Cancer Drug Targets. 2014; 14(1):70-8.
    View in: PubMed
    Score: 0.006
  32. A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer. Ann Surg. 2013 Dec; 258(6):879-86.
    View in: PubMed
    Score: 0.006
  33. The impact of lymph node disease in extremity soft-tissue sarcomas: a population-based analysis. Am J Surg. 2013 Sep; 206(3):289-95.
    View in: PubMed
    Score: 0.006
  34. Melanoma of the external ear. J Surg Oncol. 1992 Jun; 50(2):110-4.
    View in: PubMed
    Score: 0.005
  35. Carcinoma of the cervix uteri: an assessment of the relationship of tumour proliferation to prognosis. Br J Cancer. 1992 May; 65(5):783-5.
    View in: PubMed
    Score: 0.005
  36. Complications of hepatic resection for colorectal carcinoma metastasis. Am Surg. 1992 Feb; 58(2):88-91.
    View in: PubMed
    Score: 0.005
  37. Normothermia to prevent surgical site infections after gastrointestinal surgery: holy grail or false idol? Ann Surg. 2010 Oct; 252(4):696-704.
    View in: PubMed
    Score: 0.005
  38. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes fails to predict breast cancer recurrence: a final analysis of a prospective multi-institutional cohort study. Ann Surg Oncol. 2010 Oct; 17 Suppl 3:312-20.
    View in: PubMed
    Score: 0.005
  39. Six-year experience: long-term disease control outcomes for partial breast irradiation using MammoSite balloon brachytherapy. Am J Surg. 2010 Feb; 199(2):204-9.
    View in: PubMed
    Score: 0.005
  40. A quantitative reverse transcription-PCR assay for rapid, automated analysis of breast cancer sentinel lymph nodes. J Mol Diagn. 2009 Nov; 11(6):576-82.
    View in: PubMed
    Score: 0.005
  41. Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy. Brachytherapy. 2008 Oct-Dec; 7(4):305-9.
    View in: PubMed
    Score: 0.004
  42. The expression ratio of Map7/B2M is prognostic for survival in patients with stage II colon cancer. Int J Oncol. 2008 Sep; 33(3):579-84.
    View in: PubMed
    Score: 0.004
  43. Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother. 2009 Jan; 58(1):49-59.
    View in: PubMed
    Score: 0.004
  44. Accurate discrimination of pancreatic ductal adenocarcinoma and chronic pancreatitis using multimarker expression data and samples obtained by minimally invasive fine needle aspiration. Int J Cancer. 2007 Apr 01; 120(7):1511-7.
    View in: PubMed
    Score: 0.004
  45. A rapid, fully automated, molecular-based assay accurately analyzes sentinel lymph nodes for the presence of metastatic breast cancer. Ann Surg. 2006 Mar; 243(3):389-98.
    View in: PubMed
    Score: 0.004
  46. Molecular analysis improves sensitivity of breast sentinel lymph node biopsy: results of a multi-institutional prospective cohort study. Surgery. 2005 Sep; 138(3):474-81.
    View in: PubMed
    Score: 0.003
  47. An innovative microarray strategy identities informative molecular markers for the detection of micrometastatic breast cancer. Clin Cancer Res. 2005 May 15; 11(10):3697-704.
    View in: PubMed
    Score: 0.003
  48. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res. 2004 Aug 15; 64(16):5818-24.
    View in: PubMed
    Score: 0.003
  49. Comparison of poly-N-acetyl glucosamine with commercially available topical hemostats for achieving hemostasis in coagulopathic models of splenic hemorrhage. J Trauma. 2004 Jul; 57(1 Suppl):S29-32.
    View in: PubMed
    Score: 0.003
  50. Factors influencing choice between mastectomy and lumpectomy for women in the Carolinas. J Surg Oncol. 2001 Jan; 76(1):6-12.
    View in: PubMed
    Score: 0.002
  51. Melanoma thickness and histology predict sentinel lymph node status. Am J Surg. 2001 Jan; 181(1):8-11.
    View in: PubMed
    Score: 0.002
  52. The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma. Br J Cancer. 2000 Jul; 83(1):16-21.
    View in: PubMed
    Score: 0.002
  53. The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis. Br J Cancer. 1999 Nov; 81(6):1002-8.
    View in: PubMed
    Score: 0.002
  54. Trends in indications and outcomes in the Whipple procedure over a 40-year period. Am Surg. 1999 Sep; 65(9):889-93.
    View in: PubMed
    Score: 0.002
  55. Magnetic resonance cholangiopancreatography: a novel approach to the evaluation of suspected pancreaticobiliary neoplasms. Ann Surg Oncol. 1997 Dec; 4(8):634-8.
    View in: PubMed
    Score: 0.002
  56. Identification of a T-cell receptor from a therapeutic murine T-cell clone. J Immunother. 1997 Jul; 20(4):247-55.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.